106
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Biocompatible nanocomposite for PET/MRI hybrid imaging

, , , , , , , , , , , & show all
Pages 6021-6033 | Published online: 12 Dec 2012

References

  • Karim-KosHEde VriesESoerjomataramILemmensVSieslingSCoeberghJWRecent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990sEur J Cancer200844101345138918280139
  • JemalASiegelRXuJWardECancer statistics, 2010CA Cancer J Clin201060527730020610543
  • CheonJLeeJHSynergistically integrated nanoparticles as multimodal probes for nanobiotechnologyAcc Chem Res200841121630164018698851
  • CorotCRobertPIdéeJMPortMRecent advances in iron oxide nanocrystal technology for medical imagingAdv Drug Deliv Rev200658141471150417116343
  • MoghimiSMHunterACMurrayJCLong-circulating and target-specific nanoparticles: theory to practicePharmacol Rev200153228331811356986
  • HavivAHGrenècheJMLelloucheJPAggregation control of hydrophilic maghemite (gamma-Fe2O3) nanoparticles by surface doping using cerium atomsJ Am Chem Soc201013236125191252120735060
  • GrefRMinamitakeYPeracchiaMTTrubetskoyVTorchilinVLangerRBiodegradable long-circulating polymeric nanospheresScience19942635153160016038128245
  • CherrySRFundamentals of positron emission tomography and applications in preclinical drug developmentJ Clin Pharmacol200141548249111361044
  • Bond-SmithGBangaNHammondTMImberCJPancreatic adenocarcinomaBMJ2012344e247622592847
  • ZafarSFEl-RayesBFChemotherapeutic strategies in advanced or metastatic pancreatic adenocarcinomaAm J Clin Oncol Epub May 24, 2012
  • EsmanNHavivALelloucheJPMagnetically responsive polypyrrole nanotubes using Ce(III)-stabilized maghemite nanoparticlesNanotechnology2011222828560421642756
  • YuenAKHuttonGAMastersAFMaschmeyerTThe interplay of catechol ligands with nanoparticulate iron oxidesDalton Trans20124192545255922241454
  • Comes FranchiniMBaldiGBonacchiDBovine serum albumin-based magnetic nanocarrier for MRI diagnosis and hyperthermic therapy: a potential theranostic approach against cancerSmall20106336637020020469
  • BaldiGBonacchiDFranchiniMCSynthesis and coating of cobalt ferrite nanoparticles: a first step toward the obtainment of new magnetic nanocarriersLangmuir20072374026402817335257
  • Comes FranchiniMBoniniBFCamaggiCMDesign and synthesis of novel 3,4-disubstituted pyrazoles for nanomedicine applications against malignant gliomasEur J Med Chem20104552024203320129719
  • ChengJTeplyBASherifiIFormulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug deliveryBiomaterials200728586987617055572
  • LewinskiNColvinVDrezekRCytotoxicity of nanoparticlesSmall200841264918165959
  • KukisDLDirilHGreinerDPA comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugatesCancer199473Suppl 37797868306260
  • BoswellCASunXNiuWComparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexesJ Med Chem20044761465147414998334
  • HuangXZhangFLeeSLong-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobesBiomaterials201233174370437822425023
  • KoHYChoiKJLeeCHKimSA multimodal nanoparticle-based cancer imaging probe simultaneously targeting nucleolin, integrin αvβ3 and tenascin-C proteinsBiomaterials20113241130113821071077
  • MatarreseMBedeschiPScardaoniRAutomated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studiesAppl Radiat Isot201068151319736021
  • VelikyanIBeyerGJLångströmBMicrowave-supported preparation of (68)Ga bioconjugates with high specific radioactivityBioconjug Chem200415355456015149183
  • MoghimiSMHunterACAndresenTLFactors controlling nanoparticle pharmacokinetics: an integrated analysis and perspectiveAnnu Rev Pharmacol Toxicol20125248150322035254
  • KaiserEColescottRLBossingerCDCookPIColor test for detection of free terminal amino groups in the solid-phase synthesis of peptidesAnal Biochem19703425955985443684